Prognostic Factors in Advanced Non-Small-Cell Lung Cancer Patients: Patient Characteristics and Type of Chemotherapy

Table 1

Characteristics and univariate analysis of prognostic factors in treated NSCLC patients (𝑛=270).

Characteristic	N; (total = 270)	Median survival; (months)	Log-rank test; P-value
Age (years)
≤60	108	8.6	.016
<60	162	8.0
Sex
Male	228	8.2	.59
Female	42	8.3
PS
0	243	8.3	.25
1 + 2	27	6.7
Histology
Adenocarcinoma	152	8.4	.31
Others	118	8.1
Stage
IIIB	17	11.2	.075
IV	253	8.1
Smoking status
Current	209	8.1	.79
Never/former	61	8.59
Hb
≥12	219	8.1	.41
<12	51	10.2
FEV1
≥2L	128	9.2	.03
< 2L	113	8.0
Weight loss
No	190	8.2	.89
Yes	49	8.3
Sites of metastasis
Single organ	191	8.7	.68
Two or more	79	8.2
Type of chemotherapy
Platinum/Docetaxel	183	8.9	<.0001
Platinum based doublet	66	7.1
Docetaxel monotherapy	21	7.0

Abbreviations: PS: performance status; Hb: hemoglobin level in g/dL; FEV1: forced expiratory volume in one second.